RAC 4.12% $1.75 race oncology ltd

Ann: Bonus Options Prospectus, page-89

  1. 309 Posts.
    lightbulb Created with Sketch. 133
    You consistently say the update is complex and that we need to take our time to analyse it. Given your new role, I don't want to bombard you with questions. However, at the heart of RAC are retail investors who are not scientific and may even be amateur investors. Do you have any suggestions on how we should analyse it? Is there a cheat sheet for finding quotes? Personally, I look at other posters and the questions they are asking. However, I feel the discussions have been dominated by options, not the science or trials. Can you guide us back on track regarding what we should focus on?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.